![]() MarvelBiome MarvelBiome is a company focused on isolating, identifying, and characterizing microbial populations for therapeutic applications. | ![]() Curia Curia Global (formerly known as Albany Molecular Research, Inc., AMRI) is a contract research, development, and manufacturing company. | ![]() MyMeds&Me MyMeds&Me is a SaaS provider of web-based adverse event and product capture solutions for life sciences. | Reliance Life Sciences Reliance Life Sciences is a research-driven organization developing business opportunities in biotherapeutics, pharmaceuticals, clinical research services, regenerative medicine, and molecular medicine. | CoA Therapeutics CoA Therapeutics is a biopharmaceutical company developing small-molecules designed to increase Coenzyme-A (CoA) levels in genetic disorders where CoA deficiency is implicated. | |
Founding Date | Founding Date N/A | Founding Date 1991 | Founding Date 2011 | Founding Date 2001 | Founding Date 2018 |
Type | Type Private | Type Subsidiary | Type Private | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Woburn, US HQ | Locations Albany, US HQ Bon Encontre, FR Tonneins, FR Frankfurt Am Main, DE Pandharpur, IN Turkapally, IN Origgio, IT see more | Locations London, GB HQ Kingswood, GB | Locations Navi Mumbai, IN HQ Ahmedabad, IN Bengaluru, IN Kolkata, IN Lucknow, IN Ludhiana, IN New Delhi, IN see more | Locations San Francisco, US HQ |
Employees | Employees 5 | Employees 3,3741% increase | Employees 147% decrease | Employees 1,2711% decrease | Employees 7 |

Curia Global (formerly known as Albany Molecular Research, Inc., AMRI) is a contract research, development, and manufacturing company.
View company
MyMeds&Me is a SaaS provider of web-based adverse event and product capture solutions for life sciences.
View companyReliance Life Sciences is a research-driven organization developing business opportunities in biotherapeutics, pharmaceuticals, clinical research services, regenerative medicine, and molecular medicine.
View companyCoA Therapeutics is a biopharmaceutical company developing small-molecules designed to increase Coenzyme-A (CoA) levels in genetic disorders where CoA deficiency is implicated.
View company